The use of these products for thyroid disorders or menopause is often unnecessary.
- VIDEO: Endocrine Society Updates Diabetes Technology Guidelines
- VIDEO: Radioactive Iodine Use in Low-Risk Thyroid Cancer
- VIDEO: The Challenges of Thyroglobulin Assays
- VIDEO: Double Burden of Diabetes and Infectious Diseases
- VIDEO: Changes in ATA Hyperthyroidism Guideline
- VIDEO: Novel Treatments for Osteoporosis
- Revised ATA Guidelines for Thyroid in Pregnancy
- Hormone Treatment Paradigms in Transgender Medicine
- Advances in Female Fertility Preservation
Endo 2016 Complete Coverage
Chronic hypopituitarism was noted in 44% of US veterans with mild traumatic brain injury.
Phthalate exposure effect explained half of the attention deficit in children treated in the ICU.
The vaccine also restored normal glucose tolerance.
The efficacy and safety of abaloparatide was studied in a randomized, double-blind, multicenter trial evaluating fracture prevention in ambulatory, postmenopausal women with osteoporosis.
Andrew Ahmann, MD, discusses the Endocrine Society's new updates on diabetes technology.
Megan Haymart, MD, discusses new ATA guidelines for radioactive iodine treatment in thyroid cancer.
Investigational drug improved vaginal cells and vaginal pH at all dose levels.
Jonathan LoPresti, MD, PhD, discusses the challenges of taking thyroglobulin measurements at ENDO 2016.
Rocio Pereira, MD, discusses the association between diabetes and infectious diseases in developing countries.
People who lived in the warmest homes had a 2.8-cm larger waist circumference than those in the coolest homes
Sign Up for Free e-Newsletters
Check out what's trending
Endocrinology Advisor Articles
- Subclinical Hypothyroidism: Controversies in Testing and Treatment
- Favorable Outcomes With Second-Generation Insulin Analogs in Type 2 Diabetes
- Fatigue Management Contributes to Effective Endometriosis Care
- Assessment of Low-Dose Aspirin As Chemoprevention in Type 2 Diabetes
- Treatment With Alemtuzumab May Frequently Induce Thyroid Dysfunction
- Using Latent Class Trajectory Analysis to Determine Glucose Response Curve Patterns
- First CGM System With Implantable Glucose Sensor Approved
- Risk for Below Knee Amputations With Canagliflozin vs Other Antihyperglycemic Agents
- Empagliflozin, Linagliptin Combination Therapy vs Linagliptin Monotherapy for Type 2 Diabetes
- Two Phases of C-Peptide Decline Identified in Type I Diabetes
- Peer-Led Education Helps Physicians Save Time With EHRs
- As Immigration Policies Tighten, Physician Shortage Concerns Grow
- CMS Physician Payment and Policy Changes Proposed for 2019
- Severe Hypoglycemia in Type 2 Diabetes Linked to Poor Cognitive Outcomes
- eCare Plan Set to Improve Doctor/Pharmacist Relationship